Successful outcome of using recombinant activated factor VII in the management of severe bleeding due to placental abruption in a patient with anti-C and anti-e alloantibodies.
{"article_title":"[Breech Presentation: CNGOF Guidelines for Clinical Practice - Information and Management].","author":"Gallot D","journal_title":"Gynecologie, obstetrique, fertilite & senologie","issn":"2468-7189","isbn":"","publication_date":"2020-01-01","volume":"48","issue":"1","first_page":"132","page_count":"","accession_number":"31678566","doi":"10.1016\/j.gofs.2019.10.019","publisher":"Elsevier Masson SAS","doctype":"Journal Article","subjects":"France; Breech Presentation therapy; Delivery, Obstetric methods; Anesthesiologists; Cesarean Section; Delivery Rooms organization & administration; Female; France; Hospital Units; Humans; MEDLINE; Obstetrics methods; Pediatricians; Pregnancy; Version, Fetal","interest_area":["Obstetrics & Gynecology"],"abstract":"Objective: To provide guidelines regarding parents' information in case of breech presentation and labour ward organisation for trial of labour in breech presentation. Methods: Medline and Cochrane Library databases search and review of the main foreign guidelines. Results: Information should be in favour of external cephalic version and describe benefits and risks for planned vaginal delivery vs planned caesarean delivery (Professional consensus). Patient should be aware of choice change according to obstetrical context (Professional consensus). Presence of an obstetrician is required at birth as well as immediate assistance of an anaesthesiologist and paediatrician if needed (Professional consensus). Conclusion: Information should lead to concerted choice concerning mode of delivery. Labour ward organisation requires presence of an obstetrician at birth and immediate availability of anaesthesiologist and paediatrician. Copyright \u00a9 2019 Elsevier Masson SAS. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=31678566","isPdfLink":true,"isSAML":false,"an":"31678566","number_other":"","type_pub":"","issn_electronic":"2468-7189","languages":"French","language":"fre","date_entry":"Date Created: 20191104 Date Completed: 20201113 Latest Revision: 20201113","date_update":"20240104","titleSource":"Gynecologie, obstetrique, fertilite & senologie [Gynecol Obstet Fertil Senol] 2020 Jan; Vol. 48 (1), pp. 132-135. Date of Electronic Publication: 2019 Nov 01.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2020-01-01","description":"Objective: To provide guidelines regarding parents' information in case of breech presentation and labour ward organisation for trial of labour in breech presentation.<br \/>Methods: Medline and Cochrane Library databases search and review of the main foreign guidelines.<br \/>Results: Information should be in favour of external cephalic version and describe benefits and risks for planned vaginal delivery vs planned caesarean delivery (Professional consensus). Patient should be aware of choice change according to obstetrical context (Professional consensus). Presence of an obstetrician is required at birth as well as immediate assistance of an anaesthesiologist and paediatrician if needed (Professional consensus).<br \/>Conclusion: Information should lead to concerted choice concerning mode of delivery. Labour ward organisation requires presence of an obstetrician at birth and immediate availability of anaesthesiologist and paediatrician.<br \/> (Copyright © 2019 Elsevier Masson SAS. All rights reserved.)","upload_link":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=edb&AN=31678566&authtype=shib&custid=ns346513&group=main&profile=eds","no_of_pages":"","authored_by":"Gallot D","additionalInfo":{"Authored_By":"Anwar, Farzal, Abdelaal, Mohamed, Nasrallah, Fayez, El-Guindy, Abdulrahman","Published_Date":"2008-03-01","Source":"Transfusion Alternatives in Transfusion Medicine; Mar2008, Vol. 10 Issue 1, p39-41, 3p","Languages":"English","Subjects":"LETTERS to the editor, RECOMBINANT blood proteins","Title_Abbreviations":"Transfusion Alternatives in Transfusion Medicine","Volume":"10"},"header":{"DbId":"edb","DbLabel":"Complementary Index","An":"31678566","RelevancyScore":"806","PubType":"Academic Journal","PubTypeId":"academicJournal","PreciseRelevancyScore":"805.689575195313"},"plink":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&site=eds-live&db=edb&AN=31678566&authtype=shib&custid=ns346513&group=main&profile=eds"}
["Anwar, Farzal, Abdelaal, Mohamed, Nasrallah, Fayez, El-Guindy, Abdulrahman","2008-03-01","Transfusion Alternatives in Transfusion Medicine; Mar2008, Vol. 10 Issue 1, p39-41, 3p","English","LETTERS to the editor, RECOMBINANT blood proteins","Transfusion Alternatives in Transfusion Medicine","10"]
Description
A letter to the editor is presented in relation to the successful outcome of using recombinant activated factor VII in the management of severe bleeding due to placental abruption in a patient with anti-C and anti-e alloantibodies.